HK46196A - Treatment of leukocyte dysfunction with gm-csf - Google Patents

Treatment of leukocyte dysfunction with gm-csf

Info

Publication number
HK46196A
HK46196A HK46196A HK46196A HK46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A
Authority
HK
Hong Kong
Prior art keywords
csf
dysfunction
treating
treatment
leukocyte
Prior art date
Application number
HK46196A
Other languages
English (en)
Inventor
Eric M Bonnem
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK46196A publication Critical patent/HK46196A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK46196A 1989-01-30 1996-03-14 Treatment of leukocyte dysfunction with gm-csf HK46196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30439189A 1989-01-30 1989-01-30

Publications (1)

Publication Number Publication Date
HK46196A true HK46196A (en) 1996-03-22

Family

ID=23176323

Family Applications (1)

Application Number Title Priority Date Filing Date
HK46196A HK46196A (en) 1989-01-30 1996-03-14 Treatment of leukocyte dysfunction with gm-csf

Country Status (21)

Country Link
US (1) US5178855A (fr)
EP (2) EP0455726A1 (fr)
JP (1) JPH0651640B2 (fr)
KR (1) KR0137361B1 (fr)
AT (1) ATE89737T1 (fr)
AU (1) AU633054B2 (fr)
CA (1) CA2045605C (fr)
DE (1) DE69001686T2 (fr)
DK (1) DK0382381T3 (fr)
ES (1) ES2055314T3 (fr)
FI (1) FI913625A0 (fr)
HK (1) HK46196A (fr)
HU (1) HU207229B (fr)
IE (1) IE64234B1 (fr)
IL (1) IL93219A (fr)
MY (1) MY105798A (fr)
NZ (1) NZ243953A (fr)
OA (1) OA09509A (fr)
PT (1) PT92995B (fr)
WO (1) WO1990008554A1 (fr)
ZA (1) ZA90600B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081104A1 (fr) * 1991-02-22 1992-08-23 Glenn Pierce Utilisation de gm-csf et g-csf pour accelerer la guerison des plaies
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
EP0661057A4 (fr) * 1993-06-08 1997-09-03 Ajinomoto Kk Accelerateur de la proliferation des cellules hematopietiques.
JPH09509828A (ja) * 1994-03-04 1997-10-07 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 標的遺伝子損傷をした動物
US5942253A (en) 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US6753165B1 (en) * 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
EP2124897A4 (fr) * 2006-12-22 2012-05-09 Novadel Pharma Inc Préparations antinauséeuses à pulvériser, à usage oral, stables, et méthodes associées
US7826202B2 (en) * 2007-08-09 2010-11-02 Haworth, Inc. Modular electrical distribution system for a building

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
WO1987002060A1 (fr) * 1985-10-03 1987-04-09 Biogen N.V. Polypeptides semblables aux facteurs de stimulation de colonies de granulocytes-macrophages (gm-csf) et leurs procedes de production en quantites importantes dans des cellules microbiennes
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
ATE79761T1 (de) * 1985-11-27 1992-09-15 Genetics Inst Behandlung einer krankheit vom aids-typ.
HU212277B (en) * 1986-05-06 1996-04-29 Genetics Inst Process for producing m-csf
US5162111A (en) * 1986-07-30 1992-11-10 Grabstein Kenneth H Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
EP0276846A3 (fr) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Dérivés du facteur stimulant des colonies
JPH0649655B2 (ja) * 1987-11-12 1994-06-29 シェリング・コーポレーション Ｇｍ‐ｃｓｆによる骨形成の促進

Also Published As

Publication number Publication date
FI913625A0 (fi) 1991-07-30
JPH03504980A (ja) 1991-10-31
PT92995A (pt) 1990-07-31
CA2045605A1 (fr) 1990-07-31
PT92995B (pt) 1995-12-29
CA2045605C (fr) 1997-02-11
US5178855A (en) 1993-01-12
EP0382381B1 (fr) 1993-05-26
ZA90600B (en) 1990-10-31
WO1990008554A1 (fr) 1990-08-09
OA09509A (en) 1992-11-15
AU633054B2 (en) 1993-01-21
KR910700069A (ko) 1991-03-13
ES2055314T3 (es) 1994-08-16
IL93219A (en) 1998-12-27
JPH0651640B2 (ja) 1994-07-06
KR0137361B1 (ko) 1998-04-25
IE900318L (en) 1990-07-30
DE69001686D1 (de) 1993-07-01
MY105798A (en) 1995-01-30
ATE89737T1 (de) 1993-06-15
AU5048890A (en) 1990-08-24
DK0382381T3 (da) 1993-07-12
IL93219A0 (en) 1990-11-05
EP0382381A1 (fr) 1990-08-16
HU207229B (en) 1993-03-29
NZ243953A (en) 1997-06-24
HUT57607A (en) 1991-12-30
DE69001686T2 (de) 1993-09-02
IE64234B1 (en) 1995-07-26
EP0455726A1 (fr) 1991-11-13

Similar Documents

Publication Publication Date Title
TW265265B (fr)
HUT63564A (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
EP0317568A4 (fr) Utilisation de stimulation de colonies de granulocytes-macrophage pour l'obtention d'un médicament pour le traitement de maladies bacteriènnes.
ZA90600B (en) Treatment of leukocyte dysefunction with gm-csf
GR3032224T3 (en) Therapeutic agent for threatened abortion.
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
GR3000751T3 (en) Tpa-containing medical composition and use thereof
EP0397211A3 (fr) Administration percutanée de la 3'-azido-3'-déoxythymidine
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
IT1246050B (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
粟坪华 et al. Observation on 38 cases of drug-induced myospasm treated with massage over the acupoints
周荣兴 et al. THE EFFECT OF ACUPUNCTURE ON THE PHAGOCYTIC ACTIVITY OF HUMAN LEUKOCYTES
Bantz et al. Ciprofloxacin treatment of deep respiratory tract infections.
Lowe et al. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
EP0282844A3 (en) Use of dopamine-agonists in the preparation of a medicament for the treatment of bone injuries
IL125789A (en) USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES
HUT54302A (en) Process for producing medicaments comprising gamma-interferon, suitable for treating cancer of the ovary
RU96115809A (ru) Способ лечения сочетанной челюстно-мозговой травмы

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)